SLC39A11 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to SLC39A11 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies	PHASE4	COMPLETED
Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes	PHASE4	COMPLETED
Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study	PHASE4	COMPLETED
Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus	PHASE3	COMPLETED
Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala	PHASE3	COMPLETED
Oral N-acetylglucosamine in Crohn's Disease	PHASE2	NOT_YET_RECRUITING
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy	PHASE2	ACTIVE_NOT_RECRUITING
Zinc Absorption From Zinc Biofortified Rice	PHASE1/PHASE2	COMPLETED
Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children	PHASE1/PHASE2	COMPLETED
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors	PHASE1	RECRUITING
Randomized Clinical Trial: IS Zinc and Zinc Ionophere EGCG as Supplement Improve Outcome of Active Pulmonary Tuberculosis	PHASE1	UNKNOWN
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism	EARLY_PHASE1	UNKNOWN
Determination of Pre-Absorptive Dissociation of Zinc From a Zinc Amino Acid Complex in Healthy Men	nan	COMPLETED
Zinc and Diabetes in Patients With Thalassemia: a Pilot Study	nan	COMPLETED
Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune Hepatitis	nan	NOT_YET_RECRUITING
Zn Supplementation in HIV Immunological Non Responders	nan	RECRUITING
Exchangeable Zinc Pool Size and Zn Absorption From Sprinkles and Traditional Foods in Pakistani Infants /Toddlers	nan	COMPLETED
Nutrigenomics of Zinc Supplementation in Insulin Secretion and Diabetes	nan	COMPLETED
Zinc Sulfate Acceptability	nan	COMPLETED
Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)	nan	COMPLETED
Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients	nan	COMPLETED
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B)	nan	COMPLETED
Efficacy of Zinc Fortified Fermented Wheat Flour	nan	COMPLETED
An Evaluation of Zinc Status Biomarkers	nan	COMPLETED
Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features	nan	UNKNOWN
Evaluation of Zinc Intake on Essential Fatty Acid Metabolism	nan	COMPLETED
Zinc and Iron Bioavailability From Biofortified Pearl Millet	nan	COMPLETED
Zinc Absorption From Fortified Water	nan	COMPLETED
Establishment of Human Cellular Disease Models for Wilson Disease	nan	COMPLETED
Iron Fortification Trail Using NaFeEDTA in Iron Deficient Lead-exposed Children	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC39A11 binder may also engage these)

Protein	Name	Similarity
Q6P6S2	—	1.000	Q6P6S2 →
Q2YDD4	—	0.999	Q2YDD4 →
Q8BWY7	—	0.991	Q8BWY7 →
Q28J44	—	0.988	Q28J44 →
A0A0H3LM39	—	0.986	A0A0H3LM39 →
B4SPV6	—	0.976	B4SPV6 →
Q6NTL1	—	0.976	Q6NTL1 →
A8ZVV7	—	0.975	A8ZVV7 →
Q06916	—	0.974	Q06916 →
Q6NRM1	—	0.973	Q6NRM1 →
Q8FTK0	—	0.973	Q8FTK0 →
P9WIA4	—	0.973	P9WIA4 →
Q5BL29	—	0.973	Q5BL29 →
P9WIA5	—	0.973	P9WIA5 →
B2UL32	—	0.973	B2UL32 →
Q5ZIU9	—	0.972	Q5ZIU9 →
Q9C9Z1	—	0.972	Q9C9Z1 →
C0PYW1	—	0.972	C0PYW1 →
B5REE9	—	0.972	B5REE9 →
Q8P8Z6	—	0.972	Q8P8Z6 →
Q57JS2	—	0.972	Q57JS2 →
B4TVS2	—	0.972	B4TVS2 →
A9MPX1	—	0.972	A9MPX1 →
Q7UBJ3	—	0.971	Q7UBJ3 →
C4ZQV8	—	0.971	C4ZQV8 →
B7LZI9	—	0.971	B7LZI9 →
A8A4J6	—	0.971	A8A4J6 →
P65713	—	0.971	P65713 →
B7N0I9	—	0.971	B7N0I9 →
Q32BU5	—	0.971	Q32BU5 →